N-α-Fmoc-D-2,4-diaminobutyric acid

N-α-Fmoc-D-2,4-diaminobutyric acid is an Fmoc-protected D-configured amino acid derivative featuring a chiral α-center and a side chain bearing two primary amines at the 2- and 4-positions relative to the backbone. The molecule combines an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the α-amine with free, nucleophilic side-chain amino functionalities that can participate in selective acylation, alkylation, or orthogonal protection strategies. The presence of multiple amines creates a defined orthogonality landscape for peptide coupling chemistry, enabling controlled formation of amide bonds while preserving one or both side-chain nitrogens for subsequent derivatization. As a chiral amino acid building block and protected amino acid intermediate, it functions as a stereochemically defined precursor for incorporating diamino side-chain motifs into peptides and for preparing downstream functionalized scaffolds through predictable amine reactivity.

1. Peptide Synthesis

N-α-Fmoc-D-2,4-diaminobutyric acid supports solid-phase peptide synthesis and solution-phase peptide coupling workflows where a protected α-amine is required for iterative amide bond formation. The Fmoc group enables base-mediated deprotection to generate a reactive N-terminus for coupling, while the D stereochemistry preserves defined chiral information at the residue position. Side-chain primary amines can be selectively protected or left available depending on the desired sequence architecture, allowing controlled incorporation of diamino functionality into peptide backbones. Diamino side chains can further serve as handles for post-synthetic modification, enabling generation of peptide analogs with tailored charge density and binding properties. The compound thus functions as a stereodefined peptide building block for constructing amino acid sequences and peptidomimetic frameworks that retain orthogonally modifiable nitrogen functionality.

2. Side-Chain Functionalization

N-α-Fmoc-D-2,4-diaminobutyric acid is suitable for chemical derivatization programs that exploit its two primary side-chain amines to install urea, amide, sulfonamide, or carbamate motifs. The protected α-amine minimizes undesired crosslinking during side-chain chemistry, while the free diamines can be tuned through sequential protection, acylation, or selective alkylation to control mono- versus di-functional substitution patterns. The D-configured chiral center provides stereochemical fidelity in resulting conjugates, which can be relevant for molecular recognition studies and for generating structured cationic or hydrogen-bonding surfaces. The resulting functionalized amino acid derivatives can be used as intermediates for preparing labeled peptides, affinity reagents, or charge-modified biomolecule mimics. This makes the compound a practical platform for amino acid derivatization and downstream scaffold construction from a protected chiral diamino building block.

3. Bioconjugation Chemistry

N-α-Fmoc-D-2,4-diaminobutyric acid can be applied in bioconjugation strategies where diamino side chains provide reactive nucleophiles for coupling to activated esters, isothiocyanates, aldehydes, or electrophilic crosslinkers. The Fmoc-protected α-amine supports controlled release of the N-terminus when incorporated into peptide linkers, while the side-chain primary amines enable attachment point definition for conjugate architecture. Selective protection of one amine relative to the other can support regioselective conjugation, improving the reproducibility of labeling density and preventing uncontrolled multi-point attachment. The D stereochemistry can be preserved through the linker to maintain defined spatial orientation in conjugates used for chemical biology research. The compound therefore serves as an amino acid-based intermediate for constructing peptide-linked biomolecule conjugates and for generating functional probes with diamino-driven attachment chemistry.

4. Unnatural Amino Acid Incorporation

N-α-Fmoc-D-2,4-diaminobutyric acid is well matched to unnatural amino acid incorporation workflows that require a chiral, side-chain diamino residue to modulate peptide conformation and interaction patterns. The Fmoc group provides a standard compatibility point with peptide coupling reagents, while the D configuration enables incorporation of stereochemically inverted residues to probe structure-function relationships. The two primary amines can be orthogonally protected to control which nitrogen participates in further reactions after peptide assembly, supporting iterative functionalization of the residue side chain. The resulting D-diaminobutyric-containing peptides or peptidomimetics can be used as research-grade building blocks for combinatorial libraries and for mapping how side-chain charge distribution influences molecular recognition. This application category leverages protected amino acid synthesis principles to produce stereodefined, functionalized peptide analogs and chiral intermediates for applied peptide science.

5. Pharmaceutical Intermediate Preparation

N-α-Fmoc-D-2,4-diaminobutyric acid can be employed as a chiral intermediate in the manufacturing of fine chemicals and pharmaceutical process intermediates that require protected, stereochemically defined diamino motifs. The Fmoc carbamate protecting group provides a controllable N-protection handle that can be removed under standard deprotection conditions to enable downstream coupling or salt formation steps in synthetic sequences. The side-chain primary amines allow conversion into protected derivatives such as mono-Boc, acylated, or sulfonylated forms, which can be used to regulate reactivity during multistep synthesis and to manage chemoselectivity in process chemistry. The D stereocenter can be carried through to final intermediates, supporting stereochemical consistency in routes that build chiral amine-containing fragments. As a result, the compound can serve as an amino acid ester-free, N-protected chiral diamino building block for specialty chemical production and controlled intermediate generation.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Implications of ligand-receptor binding kinetics on GLP-1R signalling

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling